Education
About Us
Working with TipRanks
Follow Us
Co-Diagnostics Inc (CODX)
NASDAQ:CODX
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.33Last Year’s EPS
-0.31Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 27, 2025
|% Change Since: -17.95%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant advancements in the Co-Dx PCR platform and test pipeline, supported by external organizations, and new manufacturing capabilities. However, financial challenges were evident with decreased revenue and increased legal expenses, along with a setback in regulatory progress for the COVID-19 test.Company Guidance
During the Co-Diagnostics fourth quarter and full year 2024 earnings call, CEO Dwight Egan outlined significant progress in their test pipeline and regulatory efforts, despite some setbacks. The company saw a decrease in total revenue to $3.9 million from $6.8 million in 2023, with a net loss of $37.6 million for the year. Despite these financial challenges, Co-Diagnostics advanced the development of their Co-Dx PCR platform and associated tests, including the COVID-19, TB, respiratory multiplex, and HPV tests. The company withdrew their initial 510(k) submission for the COVID-19 test due to necessary design changes but plans to resubmit with updated data. They also inaugurated new manufacturing facilities in Utah and India to support commercialization. Legal expenses increased significantly to $7.0 million due to litigation, but the company achieved a dismissal of one class action suit. Co-Diagnostics remains focused on regulatory submissions and commercialization in 2025, with a strong emphasis on operational efficiencies and maintaining a healthy balance sheet with $29.7 million in cash and equivalents.Advancements in Co-Dx PCR Platform
The development of the Co-Dx PCR platform and associated test pipeline progressed significantly in 2024. The company added important manufacturing infrastructure to support commercialization efforts.
Regulatory Progress for Co-Dx PCR COVID-19 Test
Despite challenges, the Co-Dx PCR COVID-19 test is advancing towards regulatory clearance with design updates and feedback from the FDA providing a clear path forward.
Progress in Tuberculosis Test Development
Preliminary analytical studies for the TB test were completed in 2024, with clinical evaluations planned in South Africa and India in the second half of 2025.
Support from Leading Organizations
Development efforts have been supported by organizations like the Bill & Melinda Gates Foundation and the NIH's RADx Tech program, indicating strong external validation.
New Manufacturing Facilities
In 2024, new manufacturing facilities were inaugurated in Utah and India to support the production of the Co-Dx PCR platform and other technologies, enhancing operational capabilities.
---
CODX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CODX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 27, 2025 | $0.39 | $0.32 | -17.95% |
| Nov 07, 2024 | $1.18 | $1.14 | -3.39% |
| Aug 08, 2024 | $1.02 | $1.12 | +9.80% |
| May 09, 2024 | $1.23 | $1.11 | -9.76% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Co-Diagnostics Inc (CODX) report earnings?
Co-Diagnostics Inc (CODX) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Co-Diagnostics Inc (CODX) earnings time?
Co-Diagnostics Inc (CODX) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CODX EPS forecast?
CODX EPS forecast for the fiscal quarter 2025 (Q1) is -0.33.
---